loading page

Omalizumab in children and adolescents with chronic urticaria: A 16 week real-world study
  • +3
  • Xiaoting Song,
  • Yu-di Chen,
  • Miao Yu,
  • Bo Liu,
  • Zuotao Zhao,
  • Marcus Maurer
Xiaoting Song
Peking University First Hospital
Author Profile
Yu-di Chen
Peking University First Hospital
Author Profile
Miao Yu
Peking University School of Nursing, Peking University
Author Profile
Bo Liu
Peking University First Hospital
Author Profile
Zuotao Zhao
Peking University First Hospital
Author Profile
Marcus Maurer
Charité Universitätsmedizin Berlin, Wiley
Author Profile

Peer review status:Published

28 Sep 2020Submitted to Allergy
29 Sep 2020Submission Checks Completed
29 Sep 2020Assigned to Editor
01 Oct 2020Reviewer(s) Assigned
13 Oct 2020Review(s) Completed, Editorial Evaluation Pending
05 Nov 20201st Revision Received
06 Nov 2020Submission Checks Completed
06 Nov 2020Assigned to Editor
07 Nov 2020Reviewer(s) Assigned
12 Nov 2020Review(s) Completed, Editorial Evaluation Pending
16 Nov 2020Editorial Decision: Revise Minor
18 Nov 20202nd Revision Received
19 Nov 2020Submission Checks Completed
19 Nov 2020Assigned to Editor
20 Nov 2020Reviewer(s) Assigned
20 Nov 2020Review(s) Completed, Editorial Evaluation Pending
23 Nov 2020Editorial Decision: Accept
Apr 2021Published in Allergy volume 76 issue 4 on pages 1271-1273. 10.1111/all.14686